Project Grant P20GM162339
- Federal Project Grant Award Summary The University of Oklahoma Health Sciences Center (OUHSC) received a $2.13 million Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for January 31, 2031. The award funds the Oklahoma Center for Biomedical Research Excellence in Sensory Biology (OCBRESB), a Center of Biomedical Research Excellence (COBRE) initiative...
- Federal Grant Award Summary The Oklahoma Medical Research Foundation (OMRF) received a $2.46 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 10, 2025, with a completion date of April 30, 2030. The award funds the establishment of the Center for Genomic Regulation (CGR), which serves as a collaborative research hub for the state of Oklahoma focused on advancing genomic...
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center (OUHSC) received a $633,491 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through June 30, 2030. The award supports the "Learning and Achievement in Biomedical Sciences" initiative, which aims to expand graduate education in biomedical sciences and address Oklahoma's significant...
- Federal Project Grant Award Summary The University of Oklahoma Health Sciences Center received a $700,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds a two-year investigator-initiated research project focused on elucidating the molecular, cellular, and organism-level mechanisms by which endothelial tetraspanins inhibit...
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center received a $700,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 4, 2025, with completion targeted for August 31, 2029. The award funds research investigating the role of ARID3A (A+T-Rich Interaction Domain Protein 3A) in autoimmune B cell dysfunction associated with systemic lupus erythematosus...
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center received a $393,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for June 30, 2030. The grant funds fundamental research investigating the dynamics of fungal stress responses in host environments, utilizing Nakaseomyces glabratus as a model organism. Research...
- The University of Oklahoma Health Sciences Center received a $389,310 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award supports fundamental research investigating how Receptor Activity-Modifying Proteins (RAMP1-3) alter Class B G Protein-Coupled Receptor (GPCR) hormone binding and signaling mechanisms. The research employs...
- Federal Project Grant Award Summary The University of Oklahoma Health Sciences Center received a $555,120 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 24, 2025. The grant supports a five-year research project (completion date June 30, 2030) investigating the interaction between adrenergic nerves and immune memory in lymph nodes. The research will characterize how...
- Federal Project Grant Award Summary The Oklahoma Medical Research Foundation received a $937,750 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 8, 2025, with completion targeted for May 31, 2030. This award funds fundamental research investigating the regulation of gene transcription and DNA replication by chromatin readers from the Bromodomain and Extra-Terminal Domain...
- Federal Grant Award Summary The University of Oklahoma's Office of Research Administration received a $276,308 Project Grant award dated May 15, 2025, from the National Science Foundation (NSF) Office of Integrative Activities under the Integrative Activities program (CFDA 47.083). This CAREER award, jointly funded by the Foundations of Emerging Technologies Program and the Established Program to Stimulate Competitive Research (EPSCOR), supports the development of computational and statistical...
The University of Oklahoma received a $2.55 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) beginning May 15, 2026, through January 31, 2031. This NIH Phase I COBRE (Centers of Biomedical Research Excellence) award establishes the Oklahoma Center of Immunoengineering (OCIE), which delivers integrated research infrastructure, training, and collaborative services to advance immunoengineering and omics data science research in Oklahoma. The center provides two primary research cores: the Immunomodulation Technology Core (IMTC) and the Omics Data Science Core (ODSC), which furnish specialized facilities, instrumentation, analytical tools, training programs, and access to emerging immunoengineering technologies to support research on cancer, viral infection, diabetes, and other immunologically-rooted diseases. OCIE's services address a critical gap in Oklahoma's research ecosystem by consolidating previously scattered immunoengineering resources and expertise into a coordinated network. The center delivers end-to-end technical services, mentoring, and collaboration support to research project leaders and other immunoengineering researchers, leveraging advances in machine learning, parallel computing, network analysis, and data visualization to analyze complex omics datasets and develop novel computational models. Through this centralized infrastructure investment, OCIE supports both the immediate research productivity of its users and the long-term career development of the immunoengineering research workforce across the state.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 5/7/26 |